NCT06072638 Mother-Baby Study - Eating in the Absence of Hunger (EAH)
| NCT ID | NCT06072638 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Eating Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-12-21 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2023-12-21 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will test a model of biobehavioral mechanisms involved in the development of a system of emotion, attachment, and nutritive intake in the mother-infant dyad and the association of this system with maternal feeding behavior, child eating behavior, dietary intake, and adiposity. To participate in this study the infant must also be enrolled in long-term observational study, NCT06039878.
Eligibility Criteria
The child is a participant in the observational study (NCT06039878).
Contact & Investigator
Julie Lumeng, MD
STUDY CHAIR
University of Michigan
Frequently Asked Questions
Who can join the NCT06072638 clinical trial?
This trial is open to participants of all sexes, aged 0 Days or older, studying Eating Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06072638 currently recruiting?
Yes, NCT06072638 is actively recruiting participants. Contact the research team at ajeanp@umich.edu for enrollment information.
Where is the NCT06072638 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT06072638 clinical trial?
NCT06072638 is sponsored by University of Michigan. The principal investigator is Julie Lumeng, MD at University of Michigan. The trial plans to enroll 150 participants.